Latest News about Psilocybin program
Recent news which mentions Psilocybin program
From Benzinga
Psilocybin Mushrooms For Sale: Is It Legal Anywhere In America?
February 02, 2024
Tickers
CMPS
From Benzinga
Incannex Healthcare To Open First Psychedelic-Assisted Therapy Clinic In Australia
December 22, 2023
From Benzinga
Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
December 11, 2023
From Benzinga
Alternative Treatment For Bipolar II Depression: Psilocybin Safe And Effective, AMA Study Finds
December 06, 2023
Tickers
CMPS
From Benzinga
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
December 05, 2023
From Benzinga
Global Psychedelics: Australia's Prescription Guidelines, New Zealand's Meth Addiction Treatment
November 24, 2023
From Benzinga
Nasdaq On Horizon For Psyence Group: Psilocybin Therapeutics Division Forms New Business Combination
November 16, 2023
Tickers
NCAC
From Benzinga
From Benzinga
Canada To Australia: New MDMA & Psilocybin Shipment On Its Way For Legal Therapeutic Market
November 08, 2023
Tickers
PMBHF
From Benzinga
COMPASS Pathways Q3 2023 Results: Cash Injection To Sustain Phase 3 Psilocybin Program
November 02, 2023
Tickers
CMPS
From Benzinga
Single Dose Of Cybin's Psilocybin Shows Compelling Patient Outcomes, Phase 2 Results Find
November 01, 2023
Tickers
CYBN
From Benzinga
EXCLUSIVE: Becoming Compliant In Today's Legal Psychedelics Markets With Allay Consulting
October 26, 2023
From Benzinga
EXCLUSIVE - Canada Approves First Legal Medical Psilocybin Access: Veteran To Undergo Apex's Macrodose Therapy
September 27, 2023
From Benzinga
From Benzinga
Enveric Biosciences Nabs U.S. Patent For Novel Psilocybin Derivatives, Details Here
September 21, 2023
Tickers
ENVB
From Benzinga
Congress To Discuss New Bill Banning Federal Intervention In States Where Psilocybin Is Legal
September 20, 2023
From Benzinga
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
September 11, 2023
From Benzinga
Psychedelics Reform Update: CA Bill's Final Vote, MA 2024 Legalization Ballot, HI Task Force, OR Funding And More
September 07, 2023
From Benzinga
Compass Pathways Explores AI-Powered Predictive Model On Psilocybin Therapy For Depression
September 06, 2023
Tickers
CMPS
From Benzinga
Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, New Usona Phase 2 Trial Shows
September 03, 2023
From Benzinga
From Ice Rink To Healing Haven: Former NHL Player Sets Up Psilocybin Therapy Center In Colorado
August 25, 2023
From Benzinga
Up To $285M In Financing: COMPASS Pathways' Private Placement Backed By 'Select Group' Of Investors
August 16, 2023
Tickers
CMPS
From Benzinga
Filament Health Shares Q1 2023 Financials, Material Uncertainties Upon Securing Additional Financing
August 15, 2023
From Benzinga
Mydecine Releases Q2 2023: Developer Of Smoke Cessation Psilocybin Prodrugs & MDMA Analogs
August 15, 2023
Tickers
MYCOF
From Benzinga
COMPASS Pathways Q2 2023: $148.2M Cash Position, Steady Quarter And 'Strong Progress Across The Business'
August 03, 2023
From Benzinga
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
August 03, 2023
From Benzinga
Natural Psilocybin Companies Diversify: Latest By Optimi, Red Light Holland And A European Player
August 01, 2023
From Benzinga
Jamaica Launches Organic Psilocybin Gummies & New Psychedelic Retreat: Rose Hill's New Offer
August 01, 2023
Tickers
MYCOF
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.